CS logo
small CS logo
CHU de Rouen Hopital; Service de Neurologie

Rouen, France
Centre hospitalier universitaire (CHU)

About CHU de Rouen Hopital; Service de Neurologie


Le centre hospitalier universitaire de Rouen est un ensemble de cinq hôpitaux : l'hôpital Charles-Nicolle, l'hôpital de Bois-Guillaume, l'hôpital Saint-Julien, l'hôpital d'Oissel et l'EHPAD Boucicaut.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Genentech, Inc.
2
University Hospital, Bordeaux
1
University Hospital, Clermont-Ferrand
1
Total Rows: 4

Clinical Trials at CHU de Rouen Hopital; Service de Neurologie


During the past decade, CHU de Rouen Hopital; Service de Neurologie conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years332200222211001100222200Started TrialsCompleted Trails20172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
2010-11-30
2020-09-10
Completed
799
A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
2011-04-30
2014-02-28
Completed
448
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
2012-12-07
2017-02-08
Completed
360
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
2017-06-27
2026-09-14
Active, not recruiting
316
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
2017-03-29
2019-06-11
Terminated
806
A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting
2018-08-06
2021-02-15
Completed
423

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Rouen Hopital; Service de Neurologie" #1 collaborator was "Prothena Biosciences Limited" with 2 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 10Hoffmann-La Roche: 10Genentech, Inc.: 2Genentech, Inc.: 2University Hospital, Bordeaux: 1University Hospital, Bordeaux: 1University Hospital,Clermont-Ferrand: 1University Hospital,Clermont-Ferrand: 1

Created with Highcharts 11.1.0Top CollaboratorsProthena Biosciences Limited: 2Prothena Biosciences Limited: 2Biogen: 1Biogen: 1

Clinical Trials Conditions at CHU de Rouen Hopital; Service de Neurologie


According to Clinical.Site data, the most researched conditions in "CHU de Rouen Hopital; Service de Neurologie" are "Alzheimer's Disease" (4 trials), "Multiple Sclerosis" (4 trials), "Melanoma" (1 trials), "Migraine" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "CHU de Rouen Hopital; Service de Neurologie" in a lesser frequency.

Clinical Trials Intervention Types at CHU de Rouen Hopital; Service de Neurologie


Most popular intervention types in "CHU de Rouen Hopital; Service de Neurologie" are "Drug" (12 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (3 trials), "Crenezumab" (2 trials), "Questionnaire" (2 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CHU de Rouen Hopital; Service de Neurologie


The vast majority of trials in "CHU de Rouen Hopital; Service de Neurologie" are 13 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at CHU de Rouen Hopital; Service de Neurologie


Currently, there are NaN active trials in "CHU de Rouen Hopital; Service de Neurologie". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CHU de Rouen Hopital; Service de Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CHU de Rouen Hopital; Service de Neurologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 4Phase 2: 4Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 4Recruiting: 4Active, not recruiting: 3Active, not recruiting: 3Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1